Introduction to the classification of which type of drugs Fulvestrant/Fuxit belongs to
Fulvestrant is an endocrine therapy drug specifically used to treat hormone receptor-positive breast cancer, especially when traditional hormone treatments such as tamoxifen are ineffective or the patient is resistant. As a non-steroidal anti-estrogen drug, the main mechanism of action of fulvestrant is to bind and degrade estrogen receptors, thereby preventing estrogen from activating the receptors, thereby inhibiting the growth and proliferation of tumor cells.
Fulvestrant is classified as an "estrogen receptor degrader" (SERD). Unlike other anti-oestrogen drugs (such as selective estrogen receptor modulators SERM such as tamoxifen), fulvestrant directly degrades the receptor rather than blocking the activation of the receptor. Therefore, fulvestrant acts more thoroughly and effectively avoids the stimulation of cancer cells by estrogen.

As an endocrine therapy drug, fulvestrant plays a vital role in the treatment of breast cancer, especially for thoseHER2-negative, hormone receptor-positive breast cancer patients. It can not only effectively reduce the growth rate of tumors, but also significantly extend progression-free survival and improve patients' quality of life. Fulvestrant is commonly used to treat progressive breast cancer and provides an important treatment option, especially in patients who have already received other treatments.
The unique mechanism of action of fulvestrant makes it one of the important drugs for the treatment of breast cancer. Especially in the treatment of drug-resistant breast cancer, fulvestrant has shown good efficacy. When used in combination with other drugs, it can further enhance the anti-cancer effect and become one of the standard treatments for breast cancer.
Generally speaking, fulvestrant, as an endocrine therapy drug, provides an effective treatment option for patients with hormone receptor-positive breast cancer by targeting the degradation of estrogen receptors. It is an important drug widely used in clinical practice.
Reference materials:https://medlineplus.gov/druginfo/meds/a607031.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)